PF-08046033

PF-08046033 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046033, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of PF-08046033 in Advanced Solid Tumors [Phase 1]